Evidence map›Paper›PMID 16268778›Full record

ArticleThe Biochemical journal2006

Galphaq binds to p110alpha/p85alpha phosphoinositide 3-kinase and displaces Ras.

Lisa M Ballou, Mohar Chattopadhyay, Yan Li, Suzanne Scarlata, Richard Z Lin

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Targeting PI3K/Akt signal transduction for cancer therapy.Signal transduction and targeted therapy · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. G protein-coupled receptors and the regulation of autophagy.Trends in endocrinology and metabolism: TEM · 2014
    Review
  11. Article
  12. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
    Article
  13. Article
  14. Article
  15. The emerging mechanisms of isoform-specific PI3K signalling.Nature reviews. Molecular cell biology · 2010
    Review
  16. Article
  17. The effect of membrane domains on the G protein-phospholipase Cbeta signaling pathway.Critical reviews in biochemistry and molecular biology · 2010
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lisa M BallouDepartment of Medicine, Division of Hematology, Stony Brook University, Stony Brook, NY 11794, USA.
Mohar Chattopadhyay
Yan Li
Suzanne Scarlata
Richard Z Lin
Stony Brook University · US

Funding

ACTIVATION OF PHOSPHOLIPASE C BETA BY G PROTEINSR01GM053132 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI SCARLATA, SUZANNE F · 1995 to 2014
$3.5M
Gq-Coupled Receptors Inhibit PI 3-Kinase/Akt Signaling PathwayR01DK062722 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI LIN, RICHARD Z · 2002 to 2012
$3.1M
NIDDK NIH HHS DK62722NIDDK NIH HHS R01 DK062722NIGMS NIH HHS GM53132NIGMS NIH HHS R01 GM053132
6 · The paper itself

Abstract

Several studies have reported that activation of G(q)-coupled receptors inhibits PI3K (phosphoinositide 3-kinase) signalling. In the present study, we used purified proteins to demonstrate that Galpha(q) directly inhibits p110alpha/p85alpha PI3K in a GTP-dependent manner. Activated Galpha(q) binds to the p110alpha/p85alpha PI3K with an apparent affinity that is seven times stronger than that for Galpha(q).GDP as measured by fluorescence spectroscopy. In contrast, Galpha(q) did not bind to the p110gamma PI3K. Fluorescence spectroscopy experiments also showed that Galpha(q) competes with Ras, a PI3K activator, for binding to p110alpha/p85alpha. Interestingly, co-precipitation studies using deletion mutants showed that Galpha(q) binds to the p85-binding domain of p110alpha and not to the Ras-binding domain. Expression of constitutively active Galpha(q)Q209L in cells inhibited Ras activation of the PI3K/Akt pathway but had no effect on Ras/Raf/MEK [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase] signalling. These results suggest that activation of G(q)-coupled receptors leads to increased binding of Galpha(q).GTP to some isoforms of PI3K, which might explain why these receptors inhibit this signalling pathway in certain cell types.

Indexed as

AnimalsBinding SitesCell LineChlorocebus aethiopsCOS CellsGTP-Binding Protein alpha Subunits, Gq-G11HumansPhosphatidylinositol 3-KinasesProtein BindingProtein Structure, Tertiaryras ProteinsSignal TransductionGTP-Binding Protein alpha Subunits, Gq-G11Phosphatidylinositol 3-Kinasesras Proteins

Identifiers

PMID16268778
PMCPMC1383705
OpenAlexW2139923235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.